BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 34944640)

  • 1. The Current State of Beta-Cell-Mass PET Imaging for Diabetes Research and Therapies.
    Cheung P; Eriksson O
    Biomedicines; 2021 Dec; 9(12):. PubMed ID: 34944640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnetic resonance imaging (MRI) for the assessment of myocardial viability: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(15):1-45. PubMed ID: 23074392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term intensive insulin therapy could be the preferred option for new onset Type 2 diabetes mellitus patients with HbA1c > 9.
    Weng J
    J Diabetes; 2017 Oct; 9(10):890-893. PubMed ID: 28661564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-invasive Beta-cell Imaging: Visualization, Quantification, and Beyond.
    Murakami T; Fujimoto H; Inagaki N
    Front Endocrinol (Lausanne); 2021; 12():714348. PubMed ID: 34248856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(16):1-80. PubMed ID: 23074393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [
    Cheung P; Amin MA; Zhang B; Lechi F; Korsgren O; Eriksson J; Odell LR; Eriksson O
    Pharmaceutics; 2023 Feb; 15(2):. PubMed ID: 36839820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-cell function and mass in type 2 diabetes.
    Larsen MO
    Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A nanobody-based nuclear imaging tracer targeting dipeptidyl peptidase 6 to determine the mass of human beta cell grafts in mice.
    Demine S; Garcia Ribeiro R; Thevenet J; Marselli L; Marchetti P; Pattou F; Kerr-Conte J; Devoogdt N; Eizirik DL
    Diabetologia; 2020 Apr; 63(4):825-836. PubMed ID: 31873789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ramatroban-Based Analogues Containing Fluorine Group as Potential
    Huang LA; Huang KX; Tu J; Kandeel F; Li J
    Molecules; 2021 Mar; 26(5):. PubMed ID: 33800801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current progress in non-invasive imaging of beta cell mass of the endocrine pancreas.
    Souza F; Freeby M; Hultman K; Simpson N; Herron A; Witkowsky P; Liu E; Maffei A; Harris PE
    Curr Med Chem; 2006; 13(23):2761-73. PubMed ID: 17073627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular imaging of diabetes and diabetic complications: Beyond pancreatic β-cell targeting.
    Yang J; Zhang LJ; Wang F; Hong T; Liu Z
    Adv Drug Deliv Rev; 2019 Jan; 139():32-50. PubMed ID: 30529307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular imaging of β-cells: diabetes and beyond.
    Wei W; Ehlerding EB; Lan X; Luo QY; Cai W
    Adv Drug Deliv Rev; 2019 Jan; 139():16-31. PubMed ID: 31378283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and preclinical evaluation of the CRTH2 antagonist [
    Eriksson J; Roy T; Sawadjoon S; Bachmann K; Sköld C; Larhed M; Weis J; Selvaraju RK; Korsgren O; Eriksson O; Odell LR
    Nucl Med Biol; 2019 Apr; 71():1-10. PubMed ID: 31082767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positron emission tomography study on pancreatic somatostatin receptors in normal and diabetic rats with 68Ga-DOTA-octreotide: a potential PET tracer for beta cell mass measurement.
    Sako T; Hasegawa K; Nishimura M; Kanayama Y; Wada Y; Hayashinaka E; Cui Y; Kataoka Y; Senda M; Watanabe Y
    Biochem Biophys Res Commun; 2013 Dec; 442(1-2):79-84. PubMed ID: 24220338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased VMAT2 in the pancreas of humans with type 2 diabetes mellitus measured in vivo by PET imaging.
    Cline GW; Naganawa M; Chen L; Chidsey K; Carvajal-Gonzalez S; Pawlak S; Rossulek M; Zhang Y; Bini J; McCarthy TJ; Carson RE; Calle RA
    Diabetologia; 2018 Dec; 61(12):2598-2607. PubMed ID: 29721633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noninvasive Quantitative PET Imaging in Humans of the Pancreatic Beta-Cell Mass Biomarkers VMAT2 and Dopamine D2/D3 Receptors In Vivo.
    Bini J; Carson RE; Cline GW
    Methods Mol Biol; 2023; 2592():61-74. PubMed ID: 36507985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Report of the committee on the classification and diagnostic criteria of diabetes mellitus.
    ; Seino Y; Nanjo K; Tajima N; Kadowaki T; Kashiwagi A; Araki E; Ito C; Inagaki N; Iwamoto Y; Kasuga M; Hanafusa T; Haneda M; Ueki K
    J Diabetes Investig; 2010 Oct; 1(5):212-28. PubMed ID: 24843435
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.